To Wnt or not to Wnt: the bone and joint health dilemma

Nature Reviews Rheumatology

Volumn 9, Issue 6, 2013, Pages 328-339

  Lories, Rik J ^a   Corr, Maripat ^b   Lane, Nancy E ^c  

^a SKELETAL BIOLOGY AND ENGINEERING RESEARCH CENTER   (Belgium)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CASEIN KINASE IALPHA; FRIZZLED PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; UNCLASSIFIED DRUG; WNT PROTEIN; WNT1 PROTEIN; WNT10A PROTEIN; WNT10B PROTEIN; WNT11 PROTEIN; WNT16 PROTEIN; WNT2A PROTEIN; WNT2B PROTEIN; WNT3 PROTEIN; WNT3A PROTEIN; WNT5A PROTEIN; WNT5B PROTEIN; WNT6 PROTEIN; WNT7A PROTEIN; WNT7B PROTEIN; WNT8A PROTEIN; WNT8B PROTEIN; WNT9A PROTEIN; WNT9B PROTEIN;

ANKYLOSING SPONDYLITIS; BINDING AFFINITY; BONE GROWTH; BONE REMODELING; CAUSAL ATTRIBUTION; CELL AGGREGATION; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CELL SURVIVAL; CHONDROGENESIS; DISEASE MARKER; ENCHONDRAL OSSIFICATION; GENE MUTATION; GENE OVEREXPRESSION; HIP OSTEOARTHRITIS; HOMEOSTASIS; HUMAN; NONHUMAN; OSSIFICATION; OSTEOARTHRITIS; OSTEOBLAST; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN SYNTHESIS; RECEPTOR BINDING; REVIEW; RHEUMATOID ARTHRITIS; SPONDYLARTHRITIS;

ANIMALS; ARTHRITIS; BONE DEVELOPMENT; HUMANS; JOINTS; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 84878546253     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2013.25     Document Type: Review

References (101)

1. Clevers, H & Nusse, R. Wnt/β-catenin signaling and disease. Cell 149, 1192-1205 (2012
2. Kadowaki, T., Wilder, E., Klingensmith, J., Zachary, K. & Perrimon, N. The segment polarity gene porcupine encodes a putative multitransmembrane protein involved in Wingless processing. Genes Dev. 10, 3116-3128 (1996
3. Bänziger, C. et al. Wntless, a conserved membrane protein dedicated to the secretion of Wnt proteins from signaling cells. Cell 125, 509-522 (2006
4. Tabata, T & Takei, Y. Morphogens, their identification and regulation. Development 131, 703-712 (2004
5. Mii, Y & Taira, M. Secreted Frizzled-related proteins enhance the diffusion of Wnt ligands and expand their signalling range. Development 136, 4083-4088 (2009
6. Mii, Y & Taira, M. Secreted Wnt "inhibitors" are not just inhibitors: Regulation of extracellular Wnt by secreted Frizzled-related proteins. Dev. Growth Differ. 53, 911-923 (2011
7. Bovolenta, P., Esteve, P., Ruiz, J. M., Cisneros, E. & Lopez-Rios, J. Beyond Wnt inhibition: New functions of secreted Frizzled-related proteins in development and disease. J. Cell Sci. 121, 737-746 (2008
8. Sugimura, R & Li, L. Noncanonical Wnt signaling in vertebrate development, stem cells, and diseases. Birth Defects Res. C Embryo Today 90, 243-256 (2010
9. Li, V. S. et al. Wnt signaling through inhibition of β-catenin degradation in an intact Axin1 complex. Cell 149, 1245-1256 (2012
10. Wallingford, J. B. & Mitchell, B. Strange as it may seem: The many links between Wnt signaling, planar cell polarity, and cilia. Genes Dev. 25, 201-213 (2011
11. Clark, C. E., Nourse, C. C. & Cooper, H. M. The tangled web of non-canonical Wnt signalling in neural migration. Neurosignals 20, 202-220 (2012
12. Minami, Y., Oishi, I., Endo, M. & Nishita M. ROR-family receptor tyrosine kinases in noncanonical Wnt signaling: Their implications in developmental morphogenesis and human diseases. Dev. Dyn. 239, 1-15 (2010
13. Matthews, H. K. et al. Directional migration of neural crest cells in vivo is regulated by Syndecan-4/Rac1 and non-canonical Wnt signaling/RhoA. Development 135, 1771-1780 (2008
14. Cruciat, C. M. & Niehrs, C. Secreted and transmembrane Wnt inhibitors and activators. Cold Spring Harb. Perspect. Biol. http://dx.doi.org/10.1101/ cshperspect.a015081
15. Niehrs, C. The complex world of WNT receptor signalling. Nat. Rev. Mol. Cell Biol. 13, 767-779 (2012
16. Leucht, P., Minear, S., Ten Berge, D., Nusse, R. & Helms, J. A. Translating insights from development into regenerative medicine: The function of Wnts in bone biology. Semin. Cell Dev. Biol. 19, 434-443 (2008
17. Monroe, D. G., McGee-Lawrence, M. E., Oursler, M. J. & Westendorf, J. J. Update on Wnt signaling in bone cell biology and bone disease. Gene 492, 1-18 (2012
18. Lefebvre, V. & Bhattaram, P. Vertebrate skeletogenesis. Curr. Top. Dev. Biol. 90, 291-317 (2010
19. Barrow, J. R. et al. Ectodermal Wnt3/β-catenin signaling is required for the establishment and maintenance of the apical ectodermal ridge. Genes Dev. 17, 394-409 (2003
20. Kawakami, Y. et al. WNT signals control FGF-dependent limb initiation and AER induction in the chick embryo. Cell 104, 891-900 (2001
21. Nam, J. S. et al. Mouse R-spondin2 is required for apical ectodermal ridge maintenance in the hindlimb. Dev. Biol. 311, 124-135 (2007
22. Gros, J. et al. Wnt5a/JNK and FGF/MAPK pathways regulate the cellular events shaping the vertebrate limb bud. Curr. Biol. 20, 1993-2002 (2010
23. Rudnicki, J. A. & Brown, A. M. Inhibition of chondrogenesis by Wnt gene expression in vivo and in vitro. Dev. Biol. 185, 104-118 (1997
24. Witte, F., Dokas, J., Neuendorf, F., Mundlos, S. & Stricker, S. Comprehensive expression analysis of all Wnt genes and their major secreted antagonists during mouse limb development and cartilage differentiation. Gene Expr. Patterns 9, 215-223 (2009
25. Day, T. F., Guo, X., Garrett-Beal, L. & Yang, Y. Wnt/β-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev. Cell 8, 739-750 (2005
26. Akiyama, H. et al. Interactions between SOX9 and β-catenin control chondrocyte differentiation. Genes Dev. 18, 1072-1087 (2004
27. Hill, T. P., Später, D., Taketo, M. M., Birchmeier, W. & Hartmann, C. Canonical Wnt/β-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev. Cell 8, 727-738 (2005
28. Church, V., Nohno, T., Linker, C., Marcelle, C. & Francis-West, P. Wnt regulation of chondrocyte differentiation. J. Cell Sci. 115, 4809-4818 (2002
29. Dong, Y. F., Soung do, Y., Schwarz, E. M., O'Keefe, R. J. & Drissi, H. Wnt induction of chondrocyte hypertrophy through the Runx2 transcription factor. J. Cell. Physiol. 208, 77-86 (2006
30. Guo, X., Mak, K. K., Taketo, M. M. & Yang, Y. The Wnt/β-catenin pathway interacts differentially with PTHrP signaling to control chondrocyte hypertrophy and final maturation. PLoS ONE 4, e6067 (2009
31. Tamamura, Y. et al. Developmental regulation of Wnt/β-catenin signals is required for growth plate assembly, cartilage integrity, and endochondral ossification. J. Biol. Chem. 280, 19185-19195 (2005
32. Dao, D. Y. et al. Cartilage-specific β-catenin signaling regulates chondrocyte maturation, generation of ossification centers, and perichondrial bone formation during skeletal development. J. Bone Miner. Res. 27, 1680-1694 (2012
33. Bradley, E. W. & Drissi, M. H. Wnt5a regulates chondrocyte differentiation through differential use of the CaN/NFAT and IKK/NF-κB pathways. Mol. Endocrinol. 24, 1581-1593 (2010
34. Bradley, E. W. & Drissi, M. H. Wnt5b regulates mesenchymal cell aggregation and chondrocyte differentiation through the planar cell polarity pathway. J. Cell. Physiol. 226, 1683-1693 (2011
35. Hu, H. et al. Sequential roles of Hedgehog and Wnt signaling in osteoblast development. Development 132, 49-60 (2005
36. Hartmann, C. & Tabin, C. J. Wnt-14 plays a pivotal role in inducing synovial joint formation in the developing appendicular skeleton. Cell 104, 341-351 (2001
37. Später, D., Hill, T. P., Gruber, M. & Hartmann, C. Role of canonical Wnt-signalling in joint formation. Eur. Cell. Mater. 12, 71-80 (2006
38. Später, D. et al. Wnt9a signaling is required for joint integrity and regulation of Ihh during chondrogenesis. Development 133, 3039-3049 (2006
39. Li, X. et al. Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling. J. Biol. Chem. 280, 19883-19887 (2005
40. Robling, A. G. et al. Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin. J. Biol. Chem. 283, 5866-5875 (2008
41. Baker-Lepain, J. C. et al. Variant alleles of the Wnt antagonist FRZB are determinants of hip shape and modify the relationship between hip shape and osteoarthritis. Arthritis Rheum. 64, 1457-1465 (2012
42. Loughlin, J. et al. Functional variants within the secreted frizzled-related protein 3 gene are associated with hip osteoarthritis in females. Proc. Natl Acad. Sci. USA 101, 9757-9762 (2004
43. Lane, N. E. et al. Frizzled-related protein variants are risk factors for hip osteoarthritis. Arthritis Rheum. 54, 1246-1254 (2006
44. Min, J. L. et al. Association of the Frizzled-related protein gene with symptomatic osteoarthritis at multiple sites. Arthritis Rheum. 52, 1077-1080 (2005
45. Evangelou, E. et al. Large-scale analysis of association between GDF5 and FRZB variants and osteoarthritis of the hip, knee, and hand. Arthritis Rheum. 60, 1710-1721 (2009
46. Castaño Betancourt, M. C. et al. Genome-wide association and functional studies identify the DOT1L gene to be involved in cartilage thickness and hip osteoarthritis. Proc. Natl Acad. Sci. USA 109, 8218-8223 (2012
47. Mahmoudi, T. et al. The leukemia-associated Mllt10/Af10-Dot1l are TCF4/β-catenin coactivators essential for intestinal homeostasis. PLoS Biol. 8, e1000539 (2010
48. Dell'accio, F., De Bari, C., Eltawil, N. M., Vanhummelen, P. & Pitzalis C. Identification of the molecular response of articular cartilage to injury, by microarray screening: Wnt-16 expression and signaling after injury and in osteoarthritis. Arthritis Rheum. 58, 1410-1421 (2008
49. Blom, A. B. et al. Involvement of the Wnt signaling pathway in experimental and human osteoarthritis: Prominent role of Wnt-induced signaling protein 1. Arthritis Rheum. 60, 501-512 (2009
50. Sen, M. et al. Expression and function of wingless and frizzled homologs in rheumatoid arthritis. Proc. Natl Acad. Sci. USA 97, 2791-2796 (2000
51. Nakamura, Y., Nawata, M. & Wakitani, S. Expression profiles and functional analyses of Wnt-related genes in human joint disorders. Am. J. Pathol. 167, 97-105 (2005
52. Imai, K. et al. Differential expression of Wnts and FRPs in the synovium of rheumatoid arthritis and osteoarthritis. Biochem. Biophys. Res. Commun. 345, 1615-1620 (2006
53. Sen, M. et al. Regulation of fibronectin and metalloproteinase expression by Wnt signaling in rheumatoid arthritis synoviocytes. Arthritis Rheum. 46, 2867-2877 (2002
54. Sen, M., Chamorro, M., Reifert, J., Corr, M. & Carson, D. A. Blockade of Wnt-5a/frizzled 5 signaling inhibits rheumatoid synoviocyte activation. Arthritis Rheum. 44, 772-781 (2001
55. Zhu, M. et al. Inhibition of β-catenin signaling in articular chondrocytes results in articular cartilage destruction. Arthritis Rheum. 58, 2053-2064 (2008
56. Zhu, M. et al. Activation of β-catenin signaling in articular chondrocytes leads to osteoarthritis-like phenotype in adult β-catenin conditional activation mice. J. Bone Miner. Res. 24, 12-21 (2009
57. Yuasa, T. et al. Transient activation of Wnt/β-catenin signaling induces abnormal growth plate closure and articular cartilage thickening in postnatal mice. Am. J. Pathol. 175, 1993-2003 (2009
58. Lodewyckx, L., Luyten, F. P. & Lories R. J. Genetic deletion of low-density lipoprotein receptor-related protein 5 increases cartilage degradation in instability-induced osteoarthritis. Rheumatology (Oxford) 51, 1973-1978 (2012
59. Lories, R. J. et al. Articular cartilage and biomechanical properties of the long bones in Frzb-knockout mice. Arthritis Rheum. 56, 4095-4103 (2007
60. Miclea, R. L. et al. Inhibition of GSK3β in cartilage induces osteoarthritic features through activation of the canonical Wnt signaling pathway. Osteoarthritis Cartilage 19, 1363-1372 (2011
61. Weng, L. H., Wang, C. J., Ko, J. Y., Sun, Y. C. & Wang, F. S. Control of Dkk-1 ameliorates chondrocyte apoptosis, cartilage destruction, and subchondral bone deterioration in osteoarthritic knees. Arthritis Rheum. 62, 1393-1402 (2010
62. Oh, H., Chun, C. H. & Chun, J. S. Dkk-1 expression in chondrocytes inhibits experimental osteoarthritic cartilage destruction in mice. Arthritis Rheum. 64, 2568-2578 (2012
63. Leijten, J. C. et al. Gremlin 1, frizzled-related protein, and Dkk-1 are key regulators of human articular cartilage homeostasis. Arthritis Rheum. 64, 3302-3012 (2012
64. Lodewyckx, L., Cailotto, F., Thysen, S., Luyten, F. P. & Lories, R. J. Tight regulation of wingless-type signaling in the articular cartilage-subchondral bone biomechanical unit: Transcriptomics in Frzb-knockout mice. Arthritis Res. Ther. 14, R16 (2012
65. Nalesso, G. et al. Wnt-3a modulates articular chondrocyte phenotype by activating both canonical and noncanonical pathways. J. Cell Biol. 193, 551-564 (2011
66. Cailotto, F., Sebillaud, S., Netter, P., Jouzeau, J. Y. & Bianchi, A. The inorganic pyrophosphate transporter ANK preserves the differentiated phenotype of articular chondrocyte. J. Biol. Chem. 285, 10572-10582 (2010
67. Ma, B., van Blitterswijk, C. A. & Karperien, M. A Wnt/β-catenin negative feedback loop inhibits interleukin-1-induced matrix metalloproteinase expression in human articular chondrocytes. Arthritis Rheum. 64, 2589-2600 (2012
68. Matzelle, M. M. et al. Resolution of inflammation induces osteoblast function and regulates the Wnt signaling pathway. Arthritis Rheum. 64, 1540-1550 (2012
69. Walsh, N. C. et al. Osteoblast function is compromised at sites of focal bone erosion in inflammatory arthritis. J. Bone Miner. Res. 24, 1572-1585 (2009
70. Li, X. et al. Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation. Nat. Genet. 37, 945-952 (2005
71. de Rooy, D. P. et al. Genetic studies on components of the Wnt signalling pathway and the severity of joint destruction in rheumatoid arthritis. Ann. Rheum. Dis. http://dx.doi.org/10.1136/annrheumdis-2012-202184
72. Glass, D. A. 2nd et al. Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev. Cell 8, 751-764 (2005
73. Diarra, D. et al. Dickkopf-1 is a master regulator of joint remodeling. Nat. Med. 13, 156-163 (2007
74. Maiti, G., Naskar, D. & Sen, M. The Wingless homolog Wnt5a stimulates phagocytosis but not bacterial killing. Proc. Natl Acad. Sci. USA 109, 16600-16605 (2012
75. Kim, J. et al. Wnt5a induces endothelial inflammation via β-catenin-independent signaling. J. Immunol. 185, 1274-1282 (2010
76. Maeda, K. et al. Wnt5a-ROR2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis. Nat. Med. 18, 405-412 (2012
77. Lee, Y. S. et al. The Wnt inhibitor secreted frizzled-related protein 1 (sFRP1) promotes human TH17 differentiation. Eur. J. Immunol. 42, 2564-2573 (2012
78. Dougados, M. & Baeten, D. Spondyloarthritis. Lancet 377, 2127-2137 (2011
79. Lories, R. J., Luyten, F. P. & de Vlam, K. Progress in spondylarthritis. Mechanisms of new bone formation in spondyloarthritis. Arthritis Res. Ther. 11, 221 (2009
80. Machado, P. et al. Both structural damage and inflammation of the spine contribute to impairment of spinal mobility in patients with ankylosing spondylitis. Ann. Rheum. Dis. 69, 1465-1470 (2010
81. Wanders, A. et al. Nonsteroidal anti-inflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: A randomized clinical trial. Arthritis Rheum. 52, 1756-1765 (2005
82. Poddubnyy, D. et al. Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: Results from the German Spondyloarthritis Inception Cohort. Ann. Rheum. Dis. 71, 1616-1622 (2012
83. van der Heijde, D. et al. Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept. Arthritis Rheum. 58, 1324-1331 (2008
84. Uderhardt, S. et al. Blockade of Dickkopf (Dkk)-1 induces fusion of sacroiliac joints. Ann. Rheum. Dis. 69, 592-597 (2010
85. Haynes, K. R. et al. Excessive bone formation in a mouse model of ankylosing spondylitis is associated with decreases in Wnt pathway inhibitors. Arthritis Res. Ther. 14, R253 (2012
86. Heiland, G. R. et al. High level of functional dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis. Ann. Rheum. Dis. 71, 572-574 (2012
87. Daoussis, D. et al. Evidence that Dkk-1 is dysfunctional in ankylosing spondylitis. Arthritis Rheum. 62, 150-158 (2010
88. Appel, H. et al. Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis. Arthritis Rheum. 60, 3257-3262 (2009
89. Saad, C. G. et al. Low sclerostin levels: A predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy? Arthritis Res. Ther. 14, R216 (2012
90. Lane, N. E. et al. Wnt signaling antagonists are potential prognostic biomarkers for the progression of radiographic hip osteoarthritis in elderly Caucasian women. Arthritis Rheum. 56, 3319-3325 (2007
91. Padhi, D. A. et al. The effects of multiple doses of sclerostin antibody AMG 785 in healthy men and postmenopausal women with low bone mass [abstract OP0044]. Ann. Rheum. Dis. 71 (Suppl. 3), 67-68 (2012
92. Andrade, A. C., Nilsson, O., Barnes, K. M. & Baron, J. Wnt gene expression in the post-natal growth plate: Regulation with chondrocyte differentiation. Bone 40, 1361-1369 (2007
93. Kengaku, M. et al. Distinct Wnt pathways regulating AER formation and dorsoventral polarity in the chick limb bud. Science 280, 1274-1277 (1998
94. Guo, X. et al. Wnt/β-catenin signaling is sufficient and necessary for synovial joint formation. Genes Dev. 18, 2404-2417 (2004
95. Hartmann, C. & Tabin, C. J. Dual roles of Wnt signaling during chondrogenesis in the chicken limb. Development 127, 3141-3159 (2000
96. Yang, Y., Topol, L., Lee, H. & Wu, J. Wnt5a and Wnt5b exhibit distinct activities in coordinating chondrocyte proliferation and differentiation. Development 130, 1003-1015 (2003
97. Pasold, J. et al. Reduced expression of Sfrp1 during chondrogenesis and in articular chondrocytes correlates with osteoarthritis in STR/ort mice. Exp. Cell Res. http://dx.doi.org/10.1016/j.yexcr.2012.12.012
98. Ladher, R. K. et al. Cloning and expression of the Wnt antagonists Sfrp-2 and Frzb during chick development. Dev. Biol. 218, 183-198 (2000
99. Kusu, N. et al. Sclerostin is a novel secreted osteoclast-derived bone morphogenetic protein antagonist with unique ligand specificity. J. Biol. Chem. 278, 24113-24117 (2003
100. Chan, B. Y. et al. Increased chondrocyte sclerostin may protect against cartilage degradation in osteoarthritis. Osteoarthritis Cartilage 19, 874-885 (2011
101. Roudier, M. et al. Sclerostin is expressed in articular cartilage but loss or inhibition does not affect cartilage remodeling during aging or following mechanical injury. Arthritis Rheum. http://dx.doi.org/10.1002/art. 37802